Espranor 8mg oral lyophilisates
BNF presentation 0410030A0BFABAM within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0410030A0BFABAM
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
11,350
NHS spend (£)
£479,765.80
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,307 |
| February 2025 | 35 |
| December 2024 | 727 |
| November 2024 | 866 |
| October 2024 | 1,258 |
| September 2024 | 9 |
| August 2024 | 558 |
| July 2024 | 1,193 |
| June 2024 | 69 |
| May 2024 | 889 |
| July 2021 | 934 |
| June 2021 | 951 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 618 | No data available |
| Unknown pharmacy | 596 | No data available |
| Unknown pharmacy | 420 | No data available |
| Unknown pharmacy | 357 | No data available |
| Unknown pharmacy | 298 | No data available |
| Unknown pharmacy | 293 | No data available |
| Unknown pharmacy | 289 | No data available |
| Unknown pharmacy | 270 | No data available |
| Unknown pharmacy | 258 | No data available |
| Unknown pharmacy | 255 | No data available |